Targeting Tumor Acidity Pathway Shows Promise in Ovarian Cancer
133 people reading this right now
Researchers at UT MD Anderson found that targeting tumor acidity pathway in ovarian cancer cells can help overcome PARP inhibitor resistance by restoring treatment response.
Researchers at UT MD Anderson found that targeting tumor acidity pathway in ovarian cancer cells can help overcome PARP inhibitor resistance by restoring treatment response.
Curated in the public interest from original reporting.
Read full story at Medical Xpress →
Discover more from Newz Quest
Subscribe to get the latest posts sent to your email.
[…] Read in English […]